94 related articles for article (PubMed ID: 19491650)
1. Anterior ischemic optic neuropathy after intravitreal injection of bevacizumab.
Hosseini H; Razeghinejad MR
J Neuroophthalmol; 2009 Jun; 29(2):160-1. PubMed ID: 19491650
[No Abstract] [Full Text] [Related]
2. Anterior ischemic optic neuropathy following intravitreal bevacizumab.
Huang JY; Ozaki H; Hayashi H; Uchio E
Jpn J Ophthalmol; 2010 May; 54(3):252-4. PubMed ID: 20577866
[No Abstract] [Full Text] [Related]
3. Treatment of nonarteritic anterior ischemic optic neuropathy with intravitreal bevacizumab.
Bennett JL; Thomas S; Olson JL; Mandava N
J Neuroophthalmol; 2007 Sep; 27(3):238-40. PubMed ID: 17895825
[No Abstract] [Full Text] [Related]
4. Intravitreal triamcinolone or bevacizumab for nonarteritic anterior ischemic optic neuropathy: do they merit further study?
Kelman SE
J Neuroophthalmol; 2007 Sep; 27(3):161-3. PubMed ID: 17895813
[No Abstract] [Full Text] [Related]
5. Non-arteritic ischemic optic neuropathy followed by intravitreal bevacizumab injection: is there an association?
Bodla AA; Rao P
Indian J Ophthalmol; 2010; 58(4):349-50. PubMed ID: 20534939
[No Abstract] [Full Text] [Related]
6. Is intravitreal bevacizumab an effective treatment option for nonarteritic anterior ischemic optic neuropathy?
Prescott CR; Sklar CA; Lesser RL; Adelman RA
J Neuroophthalmol; 2012 Mar; 32(1):51-3. PubMed ID: 22269947
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Nowroozzadeh MH
Retina; 2010 Sep; 30(8):1322-3; author reply 1323. PubMed ID: 20827148
[No Abstract] [Full Text] [Related]
8. Intravitreal bevacizumab injection for central serous chorioretinopathy.
Chhablani JK; Narayanan R
Retina; 2010 Sep; 30(8):1323-24; author reply 1324. PubMed ID: 20661171
[No Abstract] [Full Text] [Related]
9. Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up.
Amselem L; Cervera E; Díaz-Llopis M; Montero J; Garcia-Pous M; Udaondo P; García-Delpech S; Salom D
Eye (Lond); 2007 Apr; 21(4):566-7. PubMed ID: 17128202
[No Abstract] [Full Text] [Related]
10. Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.
Hatta Y; Ishikawa K; Nishihara H; Ozawa S; Ito Y; Terasaki H
Retina; 2010 Mar; 30(3):495-502. PubMed ID: 19996828
[TBL] [Abstract][Full Text] [Related]
11. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
Kook D; Wolf A; Kreutzer T; Neubauer A; Strauss R; Ulbig M; Kampik A; Haritoglou C
Retina; 2008 Oct; 28(8):1053-60. PubMed ID: 18779710
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study.
Kusaka S; Shima C; Wada K; Arahori H; Shimojyo H; Sato T; Fujikado T
Br J Ophthalmol; 2008 Nov; 92(11):1450-5. PubMed ID: 18621796
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy.
Avery RL; Pearlman J; Pieramici DJ; Rabena MD; Castellarin AA; Nasir MA; Giust MJ; Wendel R; Patel A
Ophthalmology; 2006 Oct; 113(10):1695.e1-15. PubMed ID: 17011951
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab local complications.
Gordon-Angelozzi M; Velez-Montoya R; Fromow-Guerra J; García-Aguirre G; Guerrero-Naranjo JL; Quiroz-Mercado H; Morales-Cantón V
Ophthalmology; 2009 Nov; 116(11):2264.e1-3. PubMed ID: 19883862
[No Abstract] [Full Text] [Related]
15. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
[No Abstract] [Full Text] [Related]
16. Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.
Ronan SM; Yoganathan P; Chien FY; Corcóstegui IA; Blumenkranz MS; Deramo VA; Elner SG; Fastenberg DA; Johnson MW; López M; Mateo C; Moshfeghi DM; Navarro R; Rosenblatt BJ; Sanislo SR; Saxe SJ; Zacks DN
Retina; 2007 Jun; 27(5):535-40. PubMed ID: 17558313
[TBL] [Abstract][Full Text] [Related]
17. Treatment of peripapillary choroidal neovascular membranes with intravitreal bevacizumab.
Figueroa MS; Noval S; Contreras I
Br J Ophthalmol; 2008 Sep; 92(9):1244-7. PubMed ID: 18621798
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal injection of bevacizumab in Eales disease.
Küçükerdönmez C; Akova YA; Yilmaz G
Ocul Immunol Inflamm; 2008; 16(1):63-5. PubMed ID: 18379947
[TBL] [Abstract][Full Text] [Related]
19. Effect of intravitreal injection of high-dose bevacizumab in monkey eyes.
Sakurai K; Akiyama H; Shimoda Y; Yoshida I; Kurabayashi M; Kishi S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4905-16. PubMed ID: 19407010
[TBL] [Abstract][Full Text] [Related]
20. Isolated sixth nerve palsy after intravitreal bevacizumab injection.
Cakmak HB; Toklu Y; Yorgun MA; Simşek S
Strabismus; 2010 Mar; 18(1):18-20. PubMed ID: 20230202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
